IndiaTickerSenores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Company dossier
Senores Pharmaceuticals
NSE:SENORES · ISIN INE0RB801010
- Close
- ₹1,318.3 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Senores Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Copy of Newspaper Publication - Senores Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Senores Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Monitoring Agency Report - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue Of Convertible Equity Warrants, For The Quarter Ended On June 30, 2026BSE · exchange filing · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Monitoring Agency ReportBSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On June 30, 2026BSE · exchange filing · pdf
Source filing Investor Presentation - Senores Pharmaceuticals LimitedNSE · investor presentation · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Appointment - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Senores Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Press Release - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Outcome of Board Meeting - Senores Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Financial Results For Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Board Meeting Intimation for Considering And Approving The Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026 And To Transact Other Business MattersBSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Senores Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Shareholders meeting - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Senores Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Senores Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On June 29, 2026BSE · exchange filing · pdf
Source filing Trading Window - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Cessation - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing General Updates - Senores Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Senores Pharmaceuticals Ltd - 544319 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015BSE · exchange filing · pdf
Source filing